Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P293: Prognosis of small intestinal ulcers (SIUs) on capsule endoscopy when magnetic resonance enterography is normal

ECCO '19 Copenhagen

Year: 2019
Authors:

B. González Suárez1,2, J. Castro-Poceiro1, A. Fernández-Clotet1, J. Feurstein2, E. Ricart1, K. Falchuk2, I. Ordás1, S. Rodriguez1, D. Pleskow2, J. LLach1, J. Panés1, A. Moss2

1Hospital Clinic, Gastroenterology Department, Barcelona, Spain, 2Inflammatory Bowel Disease Center, BIDMCand Harvard University, Boston, MA, USA

P294: Microscopic colitis: a missed opportunity to diagnose during colonoscopy

ECCO '19 Copenhagen

Year: 2019
Authors:

S. A. Raju*1, M. Kurien1, T. S. Chew1, K. Chapple2, D. S. Sanders1

1Academic Unit of Gastroenterology, Department of Infection, Immunity and Cardiovascular Disease, Sheffield, UK, 2Northern General Hospital, Sheffield, UK

P295: Impact of superimposed cytomegalovirus infection on the outcomes of ulcerative colitis flare-up

ECCO '19 Copenhagen

Year: 2019
Authors:

H. J. Kim*1, S. J. Oh1, Y-W. Kim2, J. R. Moon1, H-S. Kim3, C. K. Lee1

1Kyung Hee University School of Medicine, Department of Gastroenterology and Hepatology, Seoul, South Korea, 2Kyung Hee University School of Medicine, Department of Pathology, Seoul, South Korea, 3Yonsei University Wonju College of Medicine, Department of Internal Medicine, Wonju, South Korea

P296: Effect of upadacitinib on patient-reported symptoms by the new Ulcerative Colitis Symptoms Questionnaire (UC-SQ) in patients with moderate to severe ulcerative colitis: data from the Phase 2b study U-ACHIEVE

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Ghosh*1, F. Aberra2, R. Cross3, W. Zhou4, N. Chen4, W-J. Lee4, R. Panaccione5

1University of Birmingham, Institute of Immunology and Immunotherapy, NIHR Biomedical Research Centre, Institute of Translational Medicine, Birmingham, UK, 2Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA, 3University of Maryland School of Medicine, Baltimore, USA, 4AbbVie Inc., North Chicago, USA, 5University of Calgary, Calgary, Canada

P297: The change of bone mineral density in patients with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

W. Moon*1, S. J. Park1, M. I. Park1, S. E. Kim1, J. H. Kim1, K. Jung1

1Department of Internal Medicine, Kosin University College of Medicine, Busan, South Korea

P298: Wall thickness ratio, a new magnetic resonance parameter, predicts the outcome of biological therapy in patients with ileal and ileocolonic Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Balestrieri*1, M. Ribolsi1, A. Tullio1, E. Solida1, A. Giordano1, M. Cicala1

1Campus Bio Medico University, Digestive Disease, Rome, Italy

P299: A novel ileocolonic Crohn’s staging tool: the development and validation of an evidence-based, end-user informed radiological decision-aid

ECCO '19 Copenhagen

Year: 2019
Authors:

P. S. Morar*1,2, K. A. Wasmann3, A. C. T. Fareleira4, K. Sahnan1,2, S. O. Adegbola1,2, E. Mainta1, R. Ilangovan1, S. Arora2, N. Sevdalis5, K. Koysombat1, A. Hart1,2, D. Burling1, C. Edwards6, J. Warusavitarne1,2, A. Gupta1, W. A. Bemelman3, O. Faiz1,2

1St Mark's Hospital, London, UK, 2Imperial College London, London, UK, 3Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands, 4Centro Hospitalar S. Joao,, Porto, Portugal, 5King’s College, London, UK, 6South Devon NHS Foundation Trust,, Torbay, UK

P300: Long-term surgical outcomes following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis in a tertiary IBD centre in Brazil

ECCO '19 Copenhagen

Year: 2019
Authors:

R. S. Parra*1, M. R. Feitosa1, F. C. Pereira1, R. S. Rodrigues1, O. Féres1, J. J. Ribeiro da Rocha1

1Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil, Surgery and Anatomy, Ribeirão Preto, SP, Brazil

P301: A serological biomarker of type VIII collagen that contains the anti-angiogenic signalling molecule, vastatin, is associated with the extension of disease in ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Lindholm*1,2, L. E. Godskesen2, L. L. Langholm1, J. Kjeldsen2, A. Krag2, M. A. Karsdal1, T. Manon-Jensen1, J. H. Mortensen1

1Nordic Biosciene A/S, Biomarkers and Research, Herlev, Denmark, 2University of Southern Denmark and Odense University Hospital, Department of Medical Gastroenterology, Odense, Denmark

P302: Predictors of outcome in children with Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

M. T. Fioretti*1, C. Strisciuglio2, M. Martinelli1, P. Dolce3, G. Vallone4, A. Staiano1, E. Miele1

1University of Naples Federico II, Department of Translational Medical Science, Section of Pediatrics, Naples, Italy, 2University of Campania ‘Luigi Vanvitelli’, Department of Woman, Child and General and Specialistic Surgery, Naples, Italy, 3University of Naples Federico II, Public of Health Department, Naples, Italy, 4University of Naples Federico II, Department of Radiology Section of Pediatric Diagnostics, Naples, Italy

P303: Hyperbilirubinemia can be induced with azathioprin treatment in patients with inflammatory bowel disease: a hospital-based cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

W. Moon*1, K. I. Seo1, S. J. Park1, M. I. Park1, S. U. Lee1, B. C. Yun1, B. H. Han1, E. T. Park1, J. H. Kim1, S. E. Kim1, K. Jung1

1Department of Internal Medicine, Kosin University College of Medicine, Busan, South Korea

P304: Predicting severity in Crohn's disease

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Gouveia*1, C. Gomes1, L. Glória1, J. Torres1, M. Cravo2

1Hospital Beatriz Ângelo, Gastroenterology, Lisbon, Portugal, 2Hospital Beatriz Ângelo, Gastroenterology, Lisboa, Portugal

P305: Platelet parameters evaluation as a non-invasive marker of inflammation in Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Padysz*1, J. Banasik1, A. Gąsiorowska1

1Military Medical Academy Memorial Teaching Hospital of the Medical University of Lodz – Central Veterans’ Hospital, Department of Gastroenterology, Lodz, Poland

P306: Double balloon enteroscopy in paediatric Crohn’s disease and 10 years follow-up

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Oba*1,2, A. Carlos3, M. Azevedo3, L. Milani3, N. Freitas4, R. Toma5, M. Bibas5, A. Damião3, A. Safatle-Ribeiro3

1São Paulo University Medical School, Pediatric, São Paulo, Brazil, 2Hospital Israelita Albert Einstein, GI, São Paulo, Brazil, 3Hospital das Clínicas HCFMUSP, Gastroenterology, São Paulo, Brazil, 4Hospital das Clínicas HCFMUSP, Surgery, São Paulo, Brazil, 5Instituto da Criança HCFMUSP, Pediatric, São Paulo, Brazil

P307: The use of the patient safety form in patients with inflammatory bowel disease, can improve the low screening and starting HBV prophylaxis rates in real life

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Demir*1, E. Uçar2, M. M. Çelik2

1Mustafa Kemal University, Gastroenterology, Hatay, Turkey, 2Mustafa Kemal University, Internal Medicine, Hatay, Turkey

P308: Utility of bowel ultrasound in diagnosing disease activity in Crohn’s disease: Indian experience

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Kakkadasam Ramaswamy*1, K. V. Nagarajan1, A. Yelsangikar1, A. Nagar1, N. Bhat1

1Aster CMI Hospital, Department of Gastroenterology, Liver Diseases and Clinical Nutrition, Bangalore, India

P309: Impact of co-morbidities on loss and lack of response to anti-TNFs in inflammatory bowel disease: VERNE study

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Marín-Jiménez*1,2, G. Bastida3,4, A. Forés5, E. García-Planella6, F. Argüelles-Arias7, P. Sarasa8, I. Tagarro8, A. Fernández-Nistal8, C. Montoto8, M. Aguas3,4, J. Santos-Fernández9, M. Boscá10, R. Ferreiro-Iglesias11, O. Merino12, X. Aldeguer13, X. Cortés14,15, B. Sicilia16, F. Mesonero17, M. Barreiro-de Acosta11

1Hospital Gregorio Marañón, Department of Gastroenterology, Madrid, Spain, 2Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain, 3Hospital La Fe, Valencia, Spain, 4Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Valencia, Spain, 5Hospital General Universitario de Castellón, Castellón, Spain, 6Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 7Hospital Universitario Virgen Macarena, Sevilla, Spain, 8Takeda Farmacéutica España SA, Madrid, Spain, 9Hospital Universitario Río Hortega, Department of Gastroenterology, Valladolid, Spain, 10University Clinic Hospital of Valencia, IBD Unit, Gastroenterology Department, Valencia, Spain, 11Hospital Clínico Universitario de Santiago, Department of Gastroenterology, Santiago de Compostela, Spain, 12Hospital Universitario Cruces, Department of Gastroenterology, Bilbao, Spain, 13Hospital Dr. Josep Trueta, Department of Gastroenterology, Girona, Spain, 14Hospital de Sagunto, IBD Unit, Gastroenterology Section, Sagunto, Spain, 15University of Cardenal Herrera-CEU, Castellón, Spain, 16Hospital Universitario de Burgos, Burgos, Spain, 17Hospital Ramón y Cajal, Department of Gastroenterology, Madrid, Spain

P310: Diagnostic delay: assessment, improvement and outcome consequences in inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Vernero*1, D. G. Ribaldone1, M. Astegiano1

1città della salute e della scienza di torino, Torino, Italy

P311: Pharmacokinetics and exposure–response relationships of intravenously administered ustekinumab during induction treatment in patients with ulcerative colitis: Results from the UNIFI induction study

ECCO '19 Copenhagen

Year: 2019
Authors:

O. J. Adedokun*1, Z. Xu1, C. Marano1, C. D. O'Brien1, P. Szapary1, H. Zhang1, J. Johanns1, R. W. Leong2,3, T. Hisamatsu4, G. Van Assche5, S. Danese6, M. T. Abreu7, B. E. Sands8, W. J. Sandborn9

1Janssen Research and Development, LLC, Spring House, USA, 2Concord Hospital, Sydney, Australia, 3Macquarie University Hospital, Sydney, Australia, 4Kyorin University, Tokyo, Japan, 5University of Leuven, Leuven, Belgium, 6Humanitas Research Hospital, Milan, Italy, 7University of Miami Miller School of Medicine, Miami, USA, 8Icahn School of Medicine at Mount Sinai, New York, USA, 9University of California San Diego, La Jolla, USA

P312: Efficacy in biologic failure and non-biologic-failure populations in a Phase 3 study of ustekinumab in moderate–severe ulcerative colitis: UNIFI

ECCO '19 Copenhagen

Year: 2019
Authors:

B. E. Sands*1, L. Peyrin-Biroulet2, C. Marano3, C. D. O'Brien3, H. Zhang3, J. Johanns4, P. Szapary3, D. Rowbotham5,6, R. W. Leong7,8, R. P. Arasaradnam9, S. Danese10, G. Van Assche11, S. Targan12, W. J. Sandborn13

1Icahn School of Medicine at Mount Sinai, New York, USA, 2Nancy University Hospital, Université de Lorraine, Nancy, France, 3Janssen Research and Development, LLC, Spring House, USA, 4Janssen Research and Development, Spring House, USA, 5Auckland City Hospital, Auckland, New Zealand, 6University of Auckland, Auckland, New Zealand, 7Concord Hospital, Sydney, Australia, 8Macquarie University Hospital, Sydney, Australia, 9Warwick Medical School, University Hospital Coventry, Warwickshire, UK, 10Humanitas Research Hospital, Milan, Italy, 11University of Leuven, Leuven, Belgium, 12Cedars-Sinai Medical Center, Los Angeles, USA, 13University of California San Diego, La Jolla, USA